
Gailene Gabel
Examiner (ID: 11538)
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1678, 1641, 1677 |
| Total Applications | 1436 |
| Issued Applications | 848 |
| Pending Applications | 208 |
| Abandoned Applications | 406 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18816435
[patent_doc_number] => 20230390775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => Method and Apparatus for Dual Use Microbiology Test Card
[patent_app_type] => utility
[patent_app_number] => 17/803958
[patent_app_country] => US
[patent_app_date] => 2023-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17803958
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/803958 | Method and Apparatus for Dual Use Microbiology Test Card | Feb 5, 2023 | Pending |
Array
(
[id] => 18846125
[patent_doc_number] => 20230408529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/164275
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164275
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164275 | Immunoassays for high positively charged proteins | Feb 2, 2023 | Issued |
Array
(
[id] => 18421579
[patent_doc_number] => 20230176042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => COMPOSITIONS AND METHODS FOR PASSIVE OPTICAL BARCODING FOR MULTIPLEXED ASSAYS
[patent_app_type] => utility
[patent_app_number] => 18/105582
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105582
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/105582 | Compositions and methods for passive optical barcoding for multiplexed assays | Feb 2, 2023 | Issued |
Array
(
[id] => 18846125
[patent_doc_number] => 20230408529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/164275
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164275
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164275 | Immunoassays for high positively charged proteins | Feb 2, 2023 | Issued |
Array
(
[id] => 18498609
[patent_doc_number] => 20230221318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/094221
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094221 | T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF | Jan 5, 2023 | Pending |
Array
(
[id] => 18339991
[patent_doc_number] => 20230131940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS OF ENUMERATING PARTICLES PRESENT IN A CELL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/085476
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085476
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/085476 | METHODS OF ENUMERATING PARTICLES PRESENT IN A CELL COMPOSITION | Dec 19, 2022 | Abandoned |
Array
(
[id] => 18392668
[patent_doc_number] => 20230160887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Flow Cytometry System and Methods for the Diagnosis of Infectious Disease
[patent_app_type] => utility
[patent_app_number] => 18/070644
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070644
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070644 | Flow Cytometry System and Methods for the Diagnosis of Infectious Disease | Nov 28, 2022 | Pending |
Array
(
[id] => 18693980
[patent_doc_number] => 20230324383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR FETAL ERYTHROID CELLS
[patent_app_type] => utility
[patent_app_number] => 17/989895
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/989895 | MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR FETAL ERYTHROID CELLS | Nov 17, 2022 | Abandoned |
Array
(
[id] => 18224274
[patent_doc_number] => 20230063268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => HIGH IONIC STRENGTH DISSOCIATION ASSAY FOR HIGH DRUG TOLERANT TESTING
[patent_app_type] => utility
[patent_app_number] => 17/982361
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982361 | HIGH IONIC STRENGTH DISSOCIATION ASSAY FOR HIGH DRUG TOLERANT TESTING | Nov 6, 2022 | Pending |
Array
(
[id] => 19970680
[patent_doc_number] => 12339283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Flow cytometry evaluation of biological material for unassociated virus-size particles
[patent_app_type] => utility
[patent_app_number] => 18/052661
[patent_app_country] => US
[patent_app_date] => 2022-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 24043
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052661 | Flow cytometry evaluation of biological material for unassociated virus-size particles | Nov 3, 2022 | Issued |
Array
(
[id] => 18787272
[patent_doc_number] => 20230375540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => Protein Damage in Aging and Age-Related Diseases
[patent_app_type] => utility
[patent_app_number] => 18/052492
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052492
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052492 | Protein Damage in Aging and Age-Related Diseases | Nov 2, 2022 | Pending |
Array
(
[id] => 20316740
[patent_doc_number] => 12455286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Cytometric assays
[patent_app_type] => utility
[patent_app_number] => 17/971720
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 32
[patent_no_of_words] => 22716
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971720 | Cytometric assays | Oct 23, 2022 | Issued |
Array
(
[id] => 19638596
[patent_doc_number] => 12169201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => Antibody stain with low fluorophore ratio for staining virus-size particles
[patent_app_type] => utility
[patent_app_number] => 17/959725
[patent_app_country] => US
[patent_app_date] => 2022-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 29724
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959725
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959725 | Antibody stain with low fluorophore ratio for staining virus-size particles | Oct 3, 2022 | Issued |
Array
(
[id] => 19282897
[patent_doc_number] => 20240219373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => METHOD FOR EVALUATING EFFICACY OF ANTICANCER DRUG OR SCREENING ANTICANCER DRUG
[patent_app_type] => utility
[patent_app_number] => 17/928829
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/928829 | METHOD FOR EVALUATING EFFICACY OF ANTICANCER DRUG OR SCREENING ANTICANCER DRUG | Sep 15, 2022 | Pending |
Array
(
[id] => 18251304
[patent_doc_number] => 20230078343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => BIOMARKER TEST AND METHOD FOR ASSESSING MUCOSAL HEALING IN RESPONSE TO TREATMENT OF ULCERATIVE COLITIS
[patent_app_type] => utility
[patent_app_number] => 17/945651
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945651
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/945651 | BIOMARKER TEST AND METHOD FOR ASSESSING MUCOSAL HEALING IN RESPONSE TO TREATMENT OF ULCERATIVE COLITIS | Sep 14, 2022 | Abandoned |
Array
(
[id] => 18568298
[patent_doc_number] => 20230258634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
[patent_app_type] => utility
[patent_app_number] => 17/944439
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17944439
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/944439 | PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING | Sep 13, 2022 | Abandoned |
Array
(
[id] => 18643300
[patent_doc_number] => 11767360
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-09-26
[patent_title] => Elisa for diagnosis of
[patent_app_type] => utility
[patent_app_number] => 17/941212
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5298
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941212
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941212 | Elisa for diagnosis of | Sep 8, 2022 | Issued |
Array
(
[id] => 18094632
[patent_doc_number] => 20220412973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => METHODS OF ANALYSIS OF BLOOD FROM DECEASED DONORS
[patent_app_type] => utility
[patent_app_number] => 17/902102
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/902102 | METHODS OF ANALYSIS OF BLOOD FROM DECEASED DONORS | Sep 1, 2022 | Abandoned |
Array
(
[id] => 18537781
[patent_doc_number] => 20230242881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => PREPARATION OF FETAL NUCLEATED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTING
[patent_app_type] => utility
[patent_app_number] => 17/902095
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/902095 | Preparation of fetal nucleated red blood cells (NRBCs) for diagnostic testing | Sep 1, 2022 | Issued |
Array
(
[id] => 19004853
[patent_doc_number] => 20240068924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => SPECIMEN ENRICHMENT FOR OPTICAL TOMOGRAPHY CELL ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 17/898074
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898074 | Specimen enrichment for optical tomography cell analysis | Aug 28, 2022 | Issued |